CN111499514A
|
|
Preparation method of intermediate of roxasistat
|
CN110818714A
|
|
Synthetic method of entecavir intermediate
|
CN110759867A
|
|
Preparation method of bendamustine hydrochloride
|
CN110759912A
|
|
Preparation method of entecavir intermediate
|
CN110551114A
|
|
Preparation method of raltitrexed
|
CN110396084A
|
|
A method of preparing high-purity trityl olmesartan medoxomil
|
CN110090843A
|
|
A kind of processing method of microbial fermentation drug waste bacterial slag
|
CN108218908A
|
|
A kind of preparation method of novel androgen receptor antagonists
|
CN106366016A
|
|
Preparation method and intermediates of iopromide
|
CN105597105A
|
|
Method for preparing ferumoxytol
|
CN105384686A
|
|
Bosutinib crystallization method
|
CN105315301A
|
|
Citrate of thiadiazole DPP-IV inhibitor
|
CN105315286A
|
|
Preparation of Sitagliptin
|
CN105272983A
|
|
High-purity Pralatrexate solid and preparation method thereof
|
CN105218439A
|
|
Crystal of a kind of Rui Gefeini and preparation method thereof
|
CN104109128A
|
|
Cabozantinib malate and preparation method thereof
|
CN103910672A
|
|
Preparation method for vismodegib
|
CN103193849A
|
|
Preparation method of high-purity abiraterone acetate
|
CN103130798A
|
|
Novel crystal of tiotropium bromide
|
CN103130855A
|
|
Preparation method of decitabine
|